Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net loss $ (94,229) $ (196,736)
Adjustments to reconcile net loss to net cash used in operating activities:    
DD&A 1,034 231
Goodwill impairment 0 77,592
Gain on Series A preferred stock exchange feature 0 (2,209)
Gain on sale of securities 0 (3,481)
Share-based compensation 3,279 21,963
Share-based payments 0 19,397
Impairment charge and loss on transfer of assets 4,513 0
Net changes in working capital (Note 11) 10,591 (2,924)
Net cash used in operating activities (74,812) (86,167)
Cash flows from investing activities:    
Cash received in acquisition 0 56
Deposit for acquisition 0 8,515
Purchase of natural gas properties (255) 0
Deferred engineering costs 0 (9,000)
Proceeds from sale of asset 167 0
Purchase of property, plant and equipment (4,814) (1,101)
Proceeds from sale of available-for-sale securities 0 4,592
Net cash used in investing activities (4,902) (13,968)
Cash flows from financing activities:    
Proceeds from borrowing under term loan 59,400 0
Payments of term loan financing costs (2,179) 0
Proceeds from issuance of common stock 133,800 218,195
Tax payments for net share settlement of equity awards (Note 11) (5,733) (828)
Equity offering costs (4,090) (607)
Net cash provided by financing activities 181,198 216,760
Net increase in cash, cash equivalents and restricted cash 101,484 116,625
Cash, cash equivalents and restricted cash, beginning of period 128,273 21,398
Cash, cash equivalents and restricted cash, end of period $ 172,317 $ 138,023